Financing - December 15, 2017
SciBase secures SEK 75 million
SciBase Holding announces that the secured new share issue with preferential rights for existing shareholders has been completed and will provide the company with approximately SEK 75 million before deduction of transaction costs. A total of approximately SEK 39.2 million, corresponding to 46.1 percent of the full offering was subscribed for. Approximately SEK 36.6 million, […]
MedTech Business - November 13, 2017
First commerical US order for SciBase
SciBase has received the first commercial order in the US – from a private clinic with a focus on self-pay patients in Manhattan, New York. The order, consisting of a Nevisense system and single-use electrodes, is strategically important for the company as it can be seen as an early sign that their launch strategy is the […]
MedTech Business - November 9, 2017
SciBase receives 1 MSEK order
The company has signed a new distribution agreement in Italy with International Health and Fitness Organisation AB (IHFO), a Swedish distributor active in Italy, within a completely new customer segment. As part of the signing, SciBase received an initial order of approx. 0.5 million SEK consisting of Nevisense systems and single use electrodes for delivery during the fourth quarter 2017. […]
MedTech Business - June 30, 2017
US approval for SciBase’s Nevisense
The US Food and Drug Administration has approved the Scibase Pre-Market Approval (PMA) for its product Nevisense. Nevisense is SciBase’s device for the early detection of malignant melanoma. With the approval, SciBase can now market and sell Nevisense in the US. According to the letter from the FDA the device is: ‘intended for use on […]
Intellectual Property - May 8, 2017
SciBase receives US patent
On May 2nd 2017 SciBase received confirmation that its US patent, protecting the shape of the microneedles that enable detection of malignant melanoma in the skin using electrical impedance, has been approved. In total SciBase now has 3 patent families approved in the US and an additional family in process. “Our electrode design is one […]
Agreement - January 31, 2017
DermoScan and SciBase sign agreement
SciBase has signed an agreement with the German medical device company DermoScan to link Nevisense with its EIS measurement for early detection of malignant melanoma, with DermoScan’s digital dermoscopy system DermoGenius Ultra. DermoScan is one of Europe’s foremost manufacturers of digital dermoscopy systems. The agreement means that EIS measurements from Nevisense will be integrated as […]
